Key terms
About PETV
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company, which engages in the business of licensing and commercializing medical devices and biomaterials for the treatment and management of afflictions and diseases in animals, initially for dogs and horses. The firm's lead product includes Spryng with OsteoCushion Technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions such as osteoarthritis in dogs and horses. The company was founded by John Lai and John F. Dolan on March 31, 2009 and is headquartered in Edina, MN.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest PETV news
Mar 14
4:02pm ET
PetVivo Holdings Announces New CFO Garry Lowenthal
Mar 11
10:32am ET
PetVivo Ends ATM Sales Agreement, Raises $959k
Mar 11
10:27am ET
PetVivo terminates ATM sales agreement with ThinkEquity
Mar 11
8:10am ET
PetVivo appoints Garry Lowenthal as CFO
Mar 05
8:05am ET
PetVivo commences trading on Upstream under PETV
Feb 29
8:09am ET
PetVivo announces study results involving Spryng
Feb 27
8:09am ET
PetVivo approved to dual list on Upstream
Feb 10
4:19am ET
PetVivo Holdings Initiates New Financial Obligation
Feb 08
5:07am ET
PetVivo Holdings Strikes Key Investment Agreements
Feb 07
8:12am ET
PetVivo announces release of study results involving feline tolerance of Spryng
Jan 31
8:08am ET
PetVivo announces release of clinical study results on Spryng
Jan 26
4:42am ET
PetVivo Holdings Announces CFO Robert Folkes’ Resignation
Jan 23
8:04am ET
PetVivo receives notice of allowance from USPTO
Dec 22
8:03am ET
PetVivo announces distribution agreement with Covetrus North America
Dec 21
8:15am ET
PetVivo achieves distribution milestone passing 4500 syringes of Spryng in 2023
PETV Financials
Key terms
Ad Feedback
PETV Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
PETV Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range